These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29030744)

  • 1. Peptide Tyrosine Tyrosine 3-36 Reduces Meal Size and Activates the Enteric Neurons in Male Sprague-Dawley Rats.
    Newman KD; Mhalhal TR; Washington MC; Heath JC; Sayegh AI
    Dig Dis Sci; 2017 Dec; 62(12):3350-3358. PubMed ID: 29030744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor.
    Washington MC; Raboin SJ; Thompson W; Larsen CJ; Sayegh AI
    Brain Res; 2010 Jul; 1344():124-33. PubMed ID: 20452329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin B12 conjugation of peptide-YY(3-36) decreases food intake compared to native peptide-YY(3-36) upon subcutaneous administration in male rats.
    Henry KE; Elfers CT; Burke RM; Chepurny OG; Holz GG; Blevins JE; Roth CL; Doyle RP
    Endocrinology; 2015 May; 156(5):1739-49. PubMed ID: 25658456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-sulfated cholecystokinin-8 reduces meal size and prolongs the intermeal interval in male Sprague Dawley rats.
    Dafalla AI; Mhalhal TR; Washington MC; Spann S; Reguero AM; Morgan AL; Cruz Matos GA; Carson G; Barton KJ; Burke NA; Heath J; Sayegh AI
    Neuropeptides; 2019 Feb; 73():57-65. PubMed ID: 30470455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPY2 receptor activation in the dorsal vagal complex increases food intake and attenuates CCK-induced satiation in male rats.
    Huston NJ; Brenner LA; Taylor ZC; Ritter RC
    Am J Physiol Regul Integr Comp Physiol; 2019 Apr; 316(4):R406-R416. PubMed ID: 30726118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrin releasing peptides increase Fos-like immunoreactivity in the enteric nervous system and the dorsal vagal complex.
    Washington MC; Sayegh AI
    Peptides; 2011 Aug; 32(8):1600-5. PubMed ID: 21745514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat.
    Raboin SJ; Reeve JR; Cooper MS; Green GM; Sayegh AI
    Regul Pept; 2008 Oct; 150(1-3):73-80. PubMed ID: 18620003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats.
    Chelikani PK; Haver AC; Reidelberger RD
    Endocrinology; 2005 Feb; 146(2):879-88. PubMed ID: 15539554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous glucagon-like peptide-1 reduces body weight and cholecystokinin-8 enhances this reduction in diet-induced obese male rats.
    Mhalhal TR; Washington MC; Newman K; Heath JC; Sayegh AI
    Physiol Behav; 2017 Oct; 179():191-199. PubMed ID: 28647503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
    Riediger T; Bothe C; Becskei C; Lutz TA
    Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-sulfated cholecystokinin-8 increases enteric and hindbrain Fos-like immunoreactivity in male Sprague Dawley rats.
    Dafalla AI; Mhalhal TR; Hiscocks K; Heath J; Sayegh AI
    Brain Res; 2019 Apr; 1708():200-206. PubMed ID: 30571983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
    Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
    Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.
    Koda S; Date Y; Murakami N; Shimbara T; Hanada T; Toshinai K; Niijima A; Furuya M; Inomata N; Osuye K; Nakazato M
    Endocrinology; 2005 May; 146(5):2369-75. PubMed ID: 15718279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced hindbrain and enteric neuronal response to intestinal oleate in rats maintained on high-fat diet.
    Covasa M; Grahn J; Ritter RC
    Auton Neurosci; 2000 Oct; 84(1-2):8-18. PubMed ID: 11109985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.
    Chelikani PK; Haver AC; Reidelberger RD
    Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin releasing peptide-29 requires vagal and splanchnic neurons to evoke satiation and satiety.
    Wright SA; Washington MC; Garcia C; Sayegh AI
    Peptides; 2012 Jan; 33(1):125-31. PubMed ID: 22210008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin-33 inhibits meal size and prolongs the subsequent intermeal interval.
    Washington MC; Coggeshall J; Sayegh AI
    Peptides; 2011 May; 32(5):971-7. PubMed ID: 21335043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin-33, but not cholecystokinin-8 shows gastrointestinal site specificity in regulating feeding behaviors in male rats.
    Washington MC; Mhalhal TR; Sayegh AI
    Horm Behav; 2016 Sep; 85():36-42. PubMed ID: 27497934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-58 and cholecystokinin-8 produce similar but not identical activations of myenteric plexus and dorsal vagal complex.
    Cooper MS; Reeve JR; Raboin SJ; Abdalla MO; Green GM; Sayegh AI
    Regul Pept; 2008 Jun; 148(1-3):88-94. PubMed ID: 18455815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.